Evidence map›Paper›PMID 35601763›Full record

ArticleHelminthologia2022

Phenotypic Changes of

G L Abuelenain, Z H Fahmy, A M Elshennawy, E H A Selim, M Elhakeem, K M A Hassanein, S M Awad

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Helminthologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Evaluation of the Efficacy of Anthelmintic Drugs AgainstAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

G L AbuelenainParasitology Lab, Department of Immunology and Drug Evaluation, TBRI, Giza, Egypt.
Z H FahmyParasitology Lab, Department of Immunology and Drug Evaluation, TBRI, Giza, Egypt.
A M ElshennawyParasitology Lab, Department of Immunology and Drug Evaluation, TBRI, Giza, Egypt.
E H A SelimParasitology Lab, Department of Immunology and Drug Evaluation, TBRI, Giza, Egypt.
M ElhakeemWater Resources and Environmental Engineering, ADU, UAE.
K M A HassaneinElectron Microscope Department, Assuit University, Asyut Egypt.
S M AwadFatima College of Health Sciences, IAT, ADU UAE.
Assiut University · EGEnvironmental and Water Resources Engineering · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichinellosis is a nematode-causing disease distinguished by its continuous transmission in the carnivores and omnivores. Despite effective eradication of the enteral forms, conventional drugs fail to eliminate the migrating and muscle ones. Over the past years, researchers intensified the work on herbal medicines as alternatives or aids to albendazole, the reference drug. This research hypothesizes that the therapeutic agent absorption route could be an evidence-based carrier molecule or auxiliary drug to albendazole. Accordingly, this

Indexed as

albendazoleauxiliary drugComplimentary drugDrug discoverygarden cressmyrrhTrichinella spiralis

Identifiers

PMID35601763
PMCPMC9075874
OpenAlexW4225378001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.